TNDM
Tandem Diabetes Care·NASDAQ
--
--(--)
--
--(--)
4.93 / 10
Netural
Analyst coverage is neutral with no strong buy/sell bias (Neutral rating at 100%). However, fund-flow analysis scores 7.65/10, reflecting robust capital movement despite negative short-term flow trends across all size brackets (block, small, medium, large, extra-large). This divergence suggests institutional interest but near-term selling pressure.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-04
InstitutionStifel
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for TNDM?
- TNDM holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.93/10 (Netural).
